PDCD1 and neoplasm: For example, the sustained release of adjuvants and tumor cell membrane-coated nanoparticles from thermosensitive hydrogels could recruit DCs and induce a strong CD8+ T cell response, and the combination with antibodies targeting PD-1 could further prolong the survival time of tumor-bearing mice (Ye et al., 2019).